Categories Analysis, Health Care

How to go stock picking in a coronavirus-infected market

Bear markets can be heart-breaking. But prudent investors have already started their groundwork

Arguably the most iconic statement made by Warren Buffett to date is – “We simply attempt to be fearful when others are greedy, and to be greedy only when others are fearful.”  And there has never been a better time to heed to the Oracle of Omaha’s wise words.

While the market crash driven by the Covid-19 has eroded millions of dollars of investors’ money, it need not ideally erase investor confidence. For one, a market correction has long been predicted, especially since we were on a decade-long bull run. Even as market experts (ehm) expected it to be caused by global marco-economic factors such as the trade war or Brexit, what really pulled the plug was a microscopic virus that emerged in a populated city on the banks of river Yangtze.

The Dow Jones Industrial Average is currently 28% below the peak it hit in mid-February. And yet, there is very little reason to panic – at least as an investor. If past experience is any indicator, bear markets are relatively shorter in duration and are followed by stock rallies. These dips are also the “Black Friday sales” of promising stocks.      

empty supermarket due to covid-19
Empty shelves at a supermarket in Sydney. Photo by Prasanth U

Consistency at a discount

While it’s impossible to time the market, adding certain stable stocks to the portfolio at this dip could prove effective in the long-term. Take for example Tyson Foods, Inc. (NYSE: TSN), a stock that has been pretty consistent, though not high-growth, over the past couple of years. The stock has seen a 32% decline due to the Covid outbreak and is currently trading near a multi-year low. Even to a risk-averse investor, TSN’s current trading price should be a sensible bargain.

Tyson Foods had also recently hired a firm to accelerate its digital transformation and cut down costs; rising costs have been a major cause of concern to TSN investors of late.  Separately, if the quarantine measures associated with Covid-19 manage to drive a shift in consumer preference away from dining out,  it could add to TSN’s attractiveness.

On the other hand, be prepared to see some short-term impacts on the firm’s operations caused by travel restrictions and quarantines. In a recent 8K filing, the company said –

Our operations, or those of independent contract poultry producers and producers who provide the live animals to our production operations, may become limited in their ability to procure, deliver, or produce our food products because of transport restrictions related to quarantines or travel bans.

  • Tyson Foods Q1 2020 earnings

Meanwhile, there is an alternative to TSN in the pharmaceutical space that offers similar or more growth opportunities – Bristol Myers Squibb (NYSE: BMY). Thanks to its acquisition of Celgene last year, the company currently has a top-selling oncology therapy (Revlimid)  that is estimated to have annual sales above $10 million. The stock had soared 56% in the latter half of last year, before being weighed down by Corona fears.

Separately, the impact on its operations from the pandemic has been minimal, a company statement shows. In the report, the company says:

“All of our internal manufacturing facilities are operating as usual, along with our key contract manufacturers. We continue to hold an adequate amount of safety stock and are at an appropriate level based on anticipated needs.”

High growth at a cost

Investors with a higher risk appetite may closely watch biopharma firms that have announced research into Covid-19 treatment, such as Gilead Sciences (NASDAQ: GILD), Moderna Inc (NASDAQ: MRNA) and Novavax Inc (NASDAQ: NVAX).

Gilead had earlier obtained an orphan drug status for its experimental drug remdesivir, which would have hindered competition, in turn financially benefiting the firm. However, the company was later blasted by health activists, pointing out that Covid-19 is not a rare disease.  Gilead has said that it would ask regulators to revoke the status.  

Clinical trials are highly complicated and very difficult to predict. It will also likely take months before an FDA-approved candidate hits the shelves. Also, since Covid-19 has become a global phenomenon, many companies abroad are also rampantly working on a cure. The variables are abundant if you are betting here, but so is the upside potential.

Prudent investors have already started analyzing and targeting the most ideal candidates for their portfolio. The bear market, after all, is not going to last forever.

Most Popular

PG Earnings: Procter & Gamble Q3 profit climbs, beats estimates

Consumer goods behemoth The Procter & Gamble Company (NYSE: PG) announced financial results for the third quarter of 2024, reporting a double-digit growth in net profit. Sales rose modestly. Core

AXP Earnings: All you need to know about American Express’ Q1 2024 earnings results

American Express Company (NYSE: AXP) reported its first quarter 2024 earnings results today. Consolidated total revenues, net of interest expense, increased 11% year-over-year to $15.8 billion, driven mainly by higher

Netflix (NFLX) Q1 2024 profit tops expectations; adds 9.3Mln subscribers

Streaming giant Netflix, Inc. (NASDAQ: NFLX) Thursday reported a sharp increase in net profit for the first quarter of 2024. Revenues were up 15% year-over-year. Both numbers exceeded Wall Street's

Comments

  1. Pingback: MBA tuition fees
  2. Pingback: Finance research
  3. Pingback: Rota evaporators
  4. Pingback: pandemic
  5. Pingback: Dental Hospital
  6. Pingback: College systems
  7. Pingback: fiverrearn.com
  8. Pingback: fiverrearn.com
  9. Pingback: fiverrearn.com
  10. Pingback: fiverrearn.com
  11. Pingback: fiverrearn.com
  12. Pingback: fiverrearn.com
  13. Pingback: liv pure
  14. Pingback: hair loss
  15. Pingback: french bulldog
  16. Pingback: fiverrearn.com
  17. Pingback: fluffy bully
  18. Pingback: jute vs sisal rug
  19. Pingback: Digital Marketing
  20. Pingback: Children jewellery
  21. Pingback: slot nexus
  22. Pingback: Fiverr.Com
  23. Pingback: lean manufacturing
  24. Pingback: Warranty
  25. Pingback: Piano maintenance
  26. Pingback: FUE
  27. Pingback: Local movers
  28. Pingback: Efficient moving
  29. Pingback: Efficient moving
  30. Pingback: Classic Books 500
  31. Pingback: FiverrEarn
  32. Pingback: FiverrEarn
  33. Pingback: FiverrEarn
  34. Pingback: FiverrEarn
  35. Pingback: Speaker
  36. Pingback: FiverrEarn
  37. Pingback: partners
  38. Pingback: prodentim
  39. Pingback: fue
  40. Pingback: Immunizations
  41. Pingback: french bulldog
  42. Pingback: FiverrEarn
  43. Pingback: FiverrEarn
  44. Pingback: FiverrEarn
  45. Pingback: live sex cams
  46. Pingback: FiverrEarn
  47. Pingback: FiverrEarn
  48. Pingback: FiverrEarn
  49. Pingback: FiverrEarn
  50. Pingback: wix website
  51. Pingback: email
  52. Pingback: sns
  53. Pingback: Kuliah Termurah
  54. Pingback: FiverrEarn
  55. Pingback: FiverrEarn
  56. Pingback: FiverrEarn
  57. Pingback: FiverrEarn
  58. Pingback: bazopril legit
  59. Pingback: cheap sex cams
  60. Pingback: fullersears.com
  61. Pingback: fullersears.com
  62. Pingback: live sex cams
  63. Pingback: live sex cams
  64. Pingback: freeze dried
  65. Pingback: rare breed-trigger
  66. Pingback: 늑대닷컴
  67. Pingback: Multi-payline slot
  68. Pingback: One Peace AMV
  69. Pingback: nang delivery
  70. Pingback: allgame
  71. Pingback: 918kiss
  72. Pingback: หวย24
  73. Pingback: pg slot
  74. Pingback: cybersécurité
  75. Pingback: Raahe Guide
  76. Pingback: resort lake placid
  77. Pingback: megagame
  78. Pingback: apply evisa online
  79. Pingback: 25-06 ammo
  80. Pingback: itsMasum.Com
  81. Pingback: itsMasum.Com
  82. Pingback: nangs sydney
  83. Pingback: nangs Sydney
  84. Pingback: website
  85. Pingback: itsmasum.com
  86. Pingback: chatiw
  87. Pingback: itsmasum.com
  88. Pingback: shanghai jobs
  89. Pingback: amsterdam jobs
  90. Pingback: karachi jobs

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top